POPS! Diabetes Care, Inc. – Trademark Portfolio
Entity Type: 03
POPS! Diabetes Care, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include REBEL, OWN YOUR LIFE, and SHOW DIABETES WHO'S BOSS. The owner is based in Stillwater, MN.
14060 Ozark Ave N
Stillwater, MN 55082
Showing of trademarks Trademarks
Trademark Classifications
POPS! Diabetes Care, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does POPS! Diabetes Care, Inc. have?
POPS! Diabetes Care, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned, 3 cancelled.
What trademark classes does POPS! Diabetes Care, Inc. file in?
POPS! Diabetes Care, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are POPS! Diabetes Care, Inc.'s most well-known trademarks?
POPS! Diabetes Care, Inc.'s registered trademark portfolio includes well-known marks such as REBEL, OWN YOUR LIFE, and SHOW DIABETES WHO'S BOSS. These are among 3 currently registered trademarks in the portfolio.
What is POPS! Diabetes Care, Inc.'s trademark registration success rate?
POPS! Diabetes Care, Inc. has a 38% trademark registration rate, with 3 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.